Literature DB >> 3087876

Factors responsible for increased susceptibility of mice to intestinal colonization after treatment with streptomycin.

J U Que, S W Casey, D J Hentges.   

Abstract

Streptomycin sulfate (5 mg/ml) was added to the drinking water of Swiss white mice. After treatment for 1 week, the mice were challenged orogastrically with 10(8) Pseudomonas aeruginosa cells. The organism failed to multiply in the intestinal tract of either treated or untreated animals, but could be recovered from contents and tissues after 48 h. In a previous study, Salmonella typhimurium was shown to multiply in the intestines of streptomycin-treated but not untreated mice when 10(3) organisms were used as inoculum. Streptomycin administration had little effect on Eh, protein or carbohydrate concentrations of cecal contents, or intestinal motility. However, it caused a statistically significant increase in water content and pH of contents and a decrease in the concentrations of acetic, propionic, butyric, and valeric acids. S. typhimurium multiplied in pooled cecal contents obtained from both streptomycin-treated and untreated animals, but its multiplication rate and total populations were significantly greater in contents from treated animals. P. aeruginosa did not multiply in contents from either treated or untreated mice. Similar results were obtained when the organisms were inoculated into nutrient broth adjusted to simulate the pH levels and volatile fatty acid (VFA) concentrations in cecal contents of treated and untreated mice. The addition of brain heart infusion broth to cecal contents from untreated animals, in concentrations that support multiplication of S. typhimurium and P. aeruginosa, did not reverse inhibition. The addition of VFA to cecal contents from treated animals to equal the concentration in cecal contents from untreated animals caused inhibition of a magnitude observed in cecal contents from untreated animals. The results indicate that VFA operating at the pH level of cecal contents of conventional mice inhibit the multiplication of both S. typhimurium and P. aeruginosa and restrict colonization of the intestine by these organisms. The decrease in VFA concentrations that occurs as a result of streptomycin administration adequately explains the increased susceptibility of treated mice to colonization with S. typhimurium. It does not explain the increased susceptibility of treated mice to P. aeruginosa colonization, however.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3087876      PMCID: PMC260084          DOI: 10.1128/iai.53.1.116-123.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Antibacterial mechanisms of the mouse gut. II. The role of Eh and volatile fatty acids in the normal gut.

Authors:  G G MEYNELL
Journal:  Br J Exp Pathol       Date:  1963-04

2.  Enteric pathogen--normal flora interactions.

Authors:  D J Hentges
Journal:  Am J Clin Nutr       Date:  1970-11       Impact factor: 7.045

3.  Use of the K88 antigen for in vivo bacterial competition with porcine strains of enteropathogenic Escherichia coli.

Authors:  J N Davidson; D C Hirsh
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

4.  Role of volatile fatty acids in colonization resistance to Clostridium difficile.

Authors:  R D Rolfe
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

5.  Survival and implantation of Escherichia coli in the intestinal tract.

Authors:  R Freter; H Brickner; J Fekete; M M Vickerman; K E Carey
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

6.  RESISTANCE OF THE MOUSE'S INTESTINAL TRACT TO EXPERIMENTAL SALMONELLA INFECTION. I. FACTORS WHICH INTERFERE WITH THE INITIATION OF INFECTION BY ORAL INOCULATION.

Authors:  M BOHNHOFF; C P MILLER; W R MARTIN
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

7.  Effect of streptomycin administration on colonization resistance to Salmonella typhimurium in mice.

Authors:  J U Que; D J Hentges
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

8.  RESISTANCE OF THE MOUSE'S INTESTINAL TRACT TO EXPERIMENTAL SALMONELLA INFECTION. II. FACTORS RESPONSIBLE FOR ITS LOSS FOLLOWING STREPTOMYCIN TREATMENT.

Authors:  M BOHNHOFF; C P MILLER; W R MARTIN
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

9.  The route of enteric infection in normal mice.

Authors:  P B Carter; F M Collins
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

10.  Experimental enteric Shigella and Vibrio infections in mice and guinea pigs.

Authors:  R FRETER
Journal:  J Exp Med       Date:  1956-09-01       Impact factor: 14.307

View more
  26 in total

1.  The Vibrio parahaemolyticus ToxRS regulator is required for stress tolerance and colonization in a novel orogastric streptomycin-induced adult murine model.

Authors:  W Brian Whitaker; Michelle A Parent; Aoife Boyd; Gary P Richards; E Fidelma Boyd
Journal:  Infect Immun       Date:  2012-03-05       Impact factor: 3.441

Review 2.  Is there a role for lactobacilli in prevention of urogenital and intestinal infections?

Authors:  G Reid; A W Bruce; J A McGroarty; K J Cheng; J W Costerton
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

3.  In vivo colonization of the mouse large intestine and in vitro penetration of intestinal mucus by an avirulent smooth strain of Salmonella typhimurium and its lipopolysaccharide-deficient mutant.

Authors:  J J Nevola; D C Laux; P S Cohen
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

4.  Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis.

Authors:  Bryan Coburn; Yuling Li; David Owen; Bruce A Vallance; B Brett Finlay
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

5.  Identification of coccoid Escherichia coli BJ4 cells in the large intestine of streptomycin-treated mice.

Authors:  K A Krogfelt; L K Poulsen; S Molin
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

6.  Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine.

Authors:  Manuela Raffatellu; Michael D George; Yuko Akiyama; Michael J Hornsby; Sean-Paul Nuccio; Tatiane A Paixao; Brian P Butler; Hiutung Chu; Renato L Santos; Thorsten Berger; Tak W Mak; Renée M Tsolis; Charles L Bevins; Jay V Solnick; Satya Dandekar; Andreas J Bäumler
Journal:  Cell Host Microbe       Date:  2009-05-08       Impact factor: 21.023

7.  Salmonella infections in a cancer center.

Authors:  L M Noriega; P Van der Auwera; D Daneau; F Meunier; M Aoun
Journal:  Support Care Cancer       Date:  1994-03       Impact factor: 3.603

8.  The capsule encoding the viaB locus reduces interleukin-17 expression and mucosal innate responses in the bovine intestinal mucosa during infection with Salmonella enterica serotype Typhi.

Authors:  Manuela Raffatellu; Renato L Santos; Daniela Chessa; R Paul Wilson; Sebastian E Winter; Carlos A Rossetti; Sara D Lawhon; Hiutung Chu; Tsang Lau; Charles L Bevins; L Garry Adams; Andreas J Bäumler
Journal:  Infect Immun       Date:  2007-06-25       Impact factor: 3.441

9.  Host transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors and indigenous intestinal microbiota.

Authors:  Trevor D Lawley; Donna M Bouley; Yana E Hoy; Christine Gerke; David A Relman; Denise M Monack
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

10.  A murine model of chronic mucosal colonization by Pseudomonas aeruginosa.

Authors:  G B Pier; G Meluleni; E Neuger
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.